?? Groundbreaking News in Breast Cancer Care! The NAPBC now includes bioimpedance spectroscopy (BIS) in its updated standards for breast cancer survivorship care. Our SOZO? platform is the only FDA-cleared BIS solution for lymphedema assessment, and is leading the charge in early lymphedema detection, empowering patients and healthcare providers. We’re proud to be part of this journey toward improved survivorship. Learn more: https://ow.ly/5xr050U5NAM. #BreastCancerAwareness #Lymphoedema #Survivorship #BIS #NAPBC
ImpediMed的动态
最相关的动态
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
Matching top talent to meaningful careers at Parexel #withheart ?? Recruiting positions for US, Canada and EMEA
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
Early/Late Phase and Regulatory Strategy, RWE & RWD, Market Access, Logistics at Parexel Biotech
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
-
?? A recent survey delved into the experiences of patients with metastatic breast cancer (#MBC) regarding treatment dosing. Key findings include: ? Most MBC patients experienced significant side effects, with fatigue, nausea, low blood counts, diarrhea, and neuropathy being the most common. Many sought medical assistance and dose reduction to mitigate these side effects. ???? Patient-physician discussions about side effects were crucial. Patients felt grateful for the support and believed their doctors were attentive. ?? Patients didn't unanimously agree that higher doses were more effective. Many were open to customized dosing based on personal characteristics. ?? Innovative dosing strategies are necessary to improve the well-being of MBC patients. Personalized and patient-centered approaches can help identify the optimal dose for each patient. ?? Survey limitations: potential selection bias, underrepresentation of minorities, reliance on self-reported data and recall bias. ?? Bridging the gap between patient experiences and treatment decisions is vital in improving MBC outcomes. Let's prioritize patient-centered care and individualized dosing strategies. #PatientPerspectives #MBCTreatment #PersonalizedMedicine
The Right Dose: Results of a Patient Advocate–Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Relate
share.parexel.social
